
    
      Phase III, randomized, placebo controlled, double blind, parallel comparative study
      (Therapeutic confirmatory trial), to evaluate the efficacy and the safety of Dexmedetomidine
      in non-intubated patients who require sedation during surgery or medical procedure under
      monitored sedation care.
    
  